Abstract
The present study was undertaken to test circulating autoantibody to ATP-binding cassette C3 (ABCC3) transporter in order to confirm whether anti-ABCC3 antibody could serve as a biomarker for early diagnosis of lung cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 1737-42 |
| Number of pages | 6 |
| Journal | Journal of Cancer Research and Clinical Oncology |
| Volume | 138 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adenocarcinoma
- Autoantibodies
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Early Detection of Cancer
- Female
- Humans
- Immunoglobulin A
- Immunoglobulin G
- Lung Neoplasms
- Male
- Middle Aged
- Multidrug Resistance-Associated Proteins
- Protein Transport
- Tumor Markers, Biological
Fingerprint
Dive into the research topics of 'Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver